FrancophonIA/ELRC3.0 huggingface dataset:
English: Memantine Mylan film-coated tablets are available in blister packs of 7, 10, 14, 28, 28 x 1, 30, 42, 50, 56, 56 x 1, 60, 70, 84, 98, 98 x 1, 100, 100 x 1 or 112 film-coated tablets.
Croatian: Memantin Mylan filmom obložene tablete dostupne su u blister pakiranjima od 7, 10, 14, 28, 28 x 1, 30, 42, 50, 56, 56 x 1, 60, 70, 84, 98, 98 x 1, 100, 100 x 1 ili 112 filmom obloženih tableta.
English: Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them.
Croatian: Kao i svi drugi lijekovi, ovaj lijek može uzrokovati nuspojave, iako se neće javiti kod svakoga.
English: Clear PVC-PVdC film with push through aluminium foil lidding blisters in pack sizes of 7, 10, 14, 28, 28 x 1, 30, 42, 50, 56, 56 x 1, 60, 70, 84, 98, 98 x 1, 100, 100 x 1 or 112 film-coated tablets.
Croatian: Prozirni PVC-PVdC film s blisterima s poklopcima od aluminijske folije za protiskivanje u veličinama pakiranja od 7, 10, 14, 28, 28 x 1, 30, 42, 50, 56, 56 x 1, 60, 70, 84, 98, 98 x 1, 100, 100 x 1 ili 112 filmom obloženih tableta.
English: Common (may affect up to 1 in 10 people):
Croatian: Česte (javljaju se kod 1 od 10 korisnika):
English: From the fourth week on, the usual dose is one 20 mg tablet once a day (20 mg).
Croatian: Od četvrtog tjedna nadalje, uobičajena doza je jedna tableta od 20 mg jedanput na dan (20 mg).
English: The pack sizes 28 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in clear PVC-PVdC film with push through aluminium foil lidding perforated unit dose blisters.
Croatian: Veličine pakiranja od 28 x 1, 56 x 1, 98 x 1 i 100 x 1 filmom obložene tablete isporučuju se u prozirnom PVC-PVdC filmu s perforiranim blisterima s jediničnim dozama od aluminijske folije s poklopcima za protiskivanje.
English: Maintenance dose The recommended maintenance dose is 20 mg per day.
Croatian: Preporučena doza održavanja je 20 mg dnevno.
English: Tablet cores for 10/20 mg film-coated tablets: Cellulose, microcrystalline Croscarmellose sodium Magnesium stearate
Croatian: Jezgra tablete za 10/20 mg filmom obložene tablete celuloza, mikrokristalična karmelozanatrij, umrežena magnezijev stearat talk silicijev dioksid, koloidni bezvodni
English: Uncommon (may affect up to 1 in 100 people):
Croatian: Manje česte (javljaju se kod 1 na 100 korisnika):
English: Memantine Mylan should be administered orally once a day.
Croatian: Memantin Mylan treba primjenjivati na usta jedanput na dan.
English: one 10 mg tablet week 3
Croatian: jedna tableta od 10 mg tjedan 3
English: METHOD AND ROUTE OF ADMINISTRATION Read the package leaflet before use.
Croatian: NAČIN I PUT PRIMJENE LIJEKA Prije uporabe pročitati Uputu o lijeku.
English: From the fourth week on, the usual dose is two 10 mg tablets once a day (20 mg).
Croatian: Od četvrtog tjedna nadalje, uobičajena doza je dvije tablete od 10 mg jedanput na dan (20 mg).
English: 98 x 1 film-coated tablets 100 film-coated tablets 100 x 1 film-coated tablets 112 film-coated tablets
Croatian: 98 x 1 filmom obloženih tableta 100 filmom obloženih tableta 100 x 1 filmom obloženih tableta 112 filmom obloženih tableta
English: How to store Memantine Mylan
Croatian: Kako čuvati Memantin Mylan
English: A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients.
Croatian: Pivotalno ispitivanje monoterapije u populaciji bolesnika koji pate od umjerene do teške Alzheimerove bolesti (početne vrijednosti kratkog testa određivanja mentalnog statusa (MMSE) bile su 3 - 14) uključivalo je ukupno 252 ambulantna bolesnika.
English: INFORMATION IN BRAILLE Memantine Mylan 10 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Memantin Mylan 10 mg
English: The following adverse reactions listed in the Table below have been accumulated in clinical studies with memantine and since its introduction in the market.
Croatian: Sljedeće nuspojave koje su prikupljene tijekom kliničkih ispitivanja s memantinom i nakon stavljanja lijeka u promet su prikazane u tablici ispod.
English: The pack sizes 28 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in unit dose blisters.
Croatian: Veličine pakiranja od 28 x 1, 56 x 1, 98 x 1 i 100 x 1 filmom obložene tablete isporučuju se u blisterima s jediničnim dozama.
English: - The other ingredients are microcrystalline cellulose, croscarmellose sodium, magnesium stearate, talc and colloidal anyhdrous silica, all in the tablet core; polydextrose (E1200), titanium dioxide (E171), hypromellose 3cP (E464), hypromellose 6cP (E464), hypromellose 50cP (E464), iron oxide yellow (E172), macrogol 400 (E1521), macrogol 8000, indigo carmine aluminium lake (E132) and iron oxide red (E172), all in the tablet coating.
Croatian: - Ostali sastojci su mikrokristalična celuloza, umreženi karmelozanatrij, magnezijev stearat, talk i koloidni bezvodni silicijev dioksid sve u jezgri tablete; polidekstroza (E1200), titanijev dioksid (E171), hipromeloza 3cP (E464), hipromeloza 6cP (E464), hipromeloza 50cP (E464), žuti željezov oksid (E172), makrogol 400 (E1521), makrogol 8000, indigo karmin »aluminium lake« (E132) i crveni željezov oksid (E172), sve u ovojnici tablete.
English: Breast-feeding Women taking Memantine Mylan should not breast-feed.
Croatian: Dojenje Žene koje uzimaju Memantin Mylan ne bi trebale dojiti.
English: INFORMATION IN BRAILLE Memantine Mylan 20 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Memantin Mylan 20 mg
English: one and a half 10 mg tablets week 4 and beyond one 20 mg tablet once a day
Croatian: jedna i pol tableta od 10 mg tjedan 4 i nakon toga jedna tableta od 20 mg jednom dnevno
English: - The other ingredients are microcrystalline cellulose, croscarmellose sodium, magnesium stearate, talc and colloidal anyhdrous silica, all in the tablet core; polydextrose (E1200), hypromellose 3cP (E464), hypromellose 6cP (E464), hypromellose 50cP (E464), iron oxide red (E172), macrogol 400 (E1521), macrogol 8000, all in the tablet coating.
Croatian: - Ostali sastojci su mikrokristalična celuloza, umreženi karmelozanatrij, magnezijev stearat, talk i koloidni bezvodni silicijev dioksid sve u jezgri tablete; polidekstroza (E1200), hipromeloza 3cP (E464), hipromeloza 6cP (E464), hipromeloza 50cP (E464), crveni željezov oksid (E172), makrogol 400 (E1521), makrogol 8000, sve u ovojnici tablete.
English: Mylan Hungary Kft. H-2900 Komárom Mylan utca.
Croatian: H-2900 Komárom Mylan utca.
English: Hallucinations1
Croatian: Manje često halucinacije1
English: This is increased to one 10 mg tablet once a day (10 mg) in the second week and to 1 and a half 10 mg tablets once a day in the third week.
Croatian: Ova se doza povećava na jednu tabletu od 10 mg jedanput na dan (10 mg) u drugom tjednu te na jednu i pol tabletu od 10 mg jednom dnevno u trećem tjednu.
English: In post-marketing experience these reactions have been reported in patients treated with memantine.
Croatian: Ove su nuspojave prijavljene u postmarketinškom razdoblju kod bolesnika liječenih memantinom.
English: From Week 4 on: The patient should take two 10 mg film-coated tablets (20 mg) or one 20 mg film-coated tablet per day.
Croatian: Bolesnik treba uzimati dvije filmom obložene tablete od 10 mg (20 mg) ili jednu filmom obloženu tabletu od 20 mg dnevno.
English: Administration of Memantine Mylan is not recommended in patients with severe hepatic impairment.
Croatian: Ne preporučuje se primjena lijeka Memantin Mylan kod bolesnika s teškim oštećenjem jetre.
English: • There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is coadministered with HCT or any combination with HCT.
Croatian: • Pri istodobnoj primjeni memantina i hidroklorotiazida (HCT-a) ili bilo koje od kombinacija s HCT-om, postoji mogućnost smanjenja koncentracije HCT-a u serumu.
English: 28 x 1 film-coated tablets 30 film-coated tablets
Croatian: 28 x 1 filmom obloženih tableta 30 filmom obloženih tableta
English: 56 x 1 film-coated tablets 60 film-coated tablets
Croatian: 56 x 1 filmom obloženih tableta 60 filmom obloženih tableta
English: one and a half 10 mg tablets week 4 and beyond two 10 mg tablets once a day
Croatian: 3. tjedan jedna i pol tableta od 10 mg 4. tjedan i nadalje dvije tablete od 10 mg jednom dnevno
English: If you take more Memantine Mylan than you should - In general, taking too much Memantine Mylan should not result in any harm to you.
Croatian: - Općenito, uzimanje previše Memantin Mylan ne bi Vam trebalo naškoditi.
English: Fertility No adverse reactions of memantine were noted on male and female fertility.
Croatian: Plodnost Nuspojave memantina vezane za plodnost muškaraca ili žena nisu bile opažene.
English: Memantine Mylan contains the active substance memantine.
Croatian: Memantin Mylan sadrži djelatnu tvar memantin.
English: Week 3 (day 15-21): The patient should take one and a half 10 mg film-coated tablets (15 mg) per day for 7 days.
Croatian: 3. tjedan (15. - 21. dan): Bolesnik treba uzimati jednu i pol filmom obloženu tabletu od 10 mg (15 mg) dnevno tijekom 7 dana.
English: half a 10 mg tablet week 2
Croatian: pola tablete od 10 mg tjedan 2
English: Tel: + 39 02 612 46921
Croatian: Mylan S.p.A Tel: + 39 02 612 46921
English: What Memantine Mylan looks like and contents of the pack A red film-coated, oval, biconvex, beveled edge tablet marked with “ME” on one side of the tablet and “20” on the other side.
Croatian: Kako Memantin Mylan izgleda i sadržaj pakiranja Filmom obložene, ovalne, bikonveksne tablete s ukošenim rubom i oznakom »ME« na jednoj strani tablete i »20« na drugoj strani.
English: Other medicines and Memantine Mylan Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate ili ste nedavno uzimali bilo koje druge lijekove, uključujući i one koje ste nabavili bez recepta.
English: 42 film-coated tablets
Croatian: 42 filmom obloženih tableta
English: A red film-coated, oval, biconvex, bevelled edge tablet debossed with “ME” on one side of the tablet and “20” on the other side.
Croatian: Crvena filmom obložena, ovalna, bikonveksna tableta zakrivljenih rubova, s ugraviranom oznakom „ME“ na jednoj strani tablete i oznakom „20“ na drugoj strani.
English: Indigo carmine aluminium lake (E132)
Croatian: Dodatno za 10 mg filmom obložene tablete titanijev dioksid (E171) željezov oksid, žuti (E172) indigo karmin »aluminium lake« (E132)
English: 84 film-coated tablets
Croatian: 84 filmom obloženih tableta
English: 70 film-coated tablets
Croatian: 70 filmom obloženih tableta
English: 7 film-coated tablets
Croatian: 7 filmom obloženih tableta
English: Each film-coated tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine.
Croatian: Jedna filmom obložena tableta sadrži 20 mg memantinklorida, što odgovara 16,62 mg memantina.
English: What Memantine Mylan looks like and contents of the pack A dark yellow film-coated, tapered oblong shaped, biconvex tablet marked with “ME” on the left of the score and “10” on the right of the score on one side of the tablet and a score on the other side.
Croatian: Kako Memantin Mylan izgleda i sadržaj pakiranja Tamnožuta filmom obložena bikonveksna tableta, suženog, duguljastog oblika, s oznakom „ME“ na lijevoj strani razdjela i oznakom „10“ na desnoj strani razdjela na jednoj strani tablete i razdjelom na drugoj strani.
English: EU/1/13/827/033 98 x 1 film-coated tablets EU/1/13/827/034 100 film-coated tablets EU/1/13/827/035 100 x 1 film-coated tablets EU/1/13/827/036 112 film-coated tablets
Croatian: EU/1/13/827/033 98 x 1 filmom obloženih tableta EU/1/13/827/034 100 filmom obloženih tableta EU/1/13/827/035 100 x 1 filmom obloženih tableta EU/1/13/827/036 112 filmom obloženih tableta
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži 10 mg memantinklorida, što odgovara 8,31 mg memantina.
English: MARKETING AUTHORISATION HOLDER Mylan S.A.S.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Mylan S.A.S.
English: Memantine Mylan 20 mg film-coated tablets
Croatian: Memantin Mylan 20 mg filmom obložene tablete
English: EU/1/13/827/023 28 x 1 film-coated tablets EU/1/13/827/024 30 film-coated tablets
Croatian: EU/1/13/827/023 28 x 1 filmom obloženih tableta EU/1/13/827/024 30 filmom obloženih tableta
English: STATEMENT OF ACTIVE SUBSTANCE Each film-coated tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV DJELATNIH TVARI Svaka filmom obložena tableta sadržava 20 mg memantinklorida, što odgovara 16,62 mg memantina.
English: Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine.
Croatian: Svaka filmom obložena tableta sadržava 10 mg memantinklorida što odgovara 8,31 mg memantina.
English: EU/1/13/827/028 56 x 1 film-coated tablets EU/1/13/827/029 60 film-coated tablets
Croatian: EU/1/13/827/028 56 x 1 filmom obloženih tableta EU/1/13/827/029 60 filmom obloženih tableta
English: EU/1/13/827/025 42 film-coated tablets
Croatian: EU/1/13/827/025 42 filmom obloženih tableta
English: NAME OF THE MEDICINAL PRODUCT Memantine Mylan 10 mg film-coated tablets Memantine Mylan 20 mg film-coated tablets
Croatian: Memantin Mylan 10 mg filmom obložene tablete Memantin Mylan 20 mg filmom obložene tablete
English: EU/1/13/827/030 70 film-coated tablets
Croatian: EU/1/13/827/030 70 filmom obloženih tableta
English: EU/1/13/827/020 10 film-coated tablets
Croatian: EU/1/13/827/020 10 filmom obloženih tableta
English: EU/1/13/827/032 98 film-coated tablets
Croatian: EU/1/13/827/032 98 filmom obloženih tableta
English: EU/1/13/827/019 7 film-coated tablets
Croatian: EU/1/13/827/019 7 filmom obloženih tableta
English: EU/1/13/827/027 56 film-coated tablets
Croatian: EU/1/13/827/027 56 filmom obloženih tableta
English: EU/1/13/827/022 28 film-coated tablets
Croatian: EU/1/13/827/022 28 filmom obloženih tableta
English: Memantine Mylan 10 mg film-coated tablets memantine hydrochloride
Croatian: Memantin Mylan 10 mg filmom obložene tablete memantinklorid
English: EU/1/13/827/026 50 film-coated tablets
Croatian: EU/1/13/827/026 50 filmom obloženih tableta
English: EU/1/13/827/031 84 film-coated tablets
Croatian: EU/1/13/827/031 84 filmom obloženih tableta
English: EU/1/13/827/001 7 film-coated tablets
Croatian: EU/1/13/827/001 7 filmom obloženih tableta
English: Memantine Mylan 20 mg film-coated tablets memantine hydrochloride
Croatian: Memantin Mylan 20 mg filmom obložene tablete memantinklorid
English: NAME OF THE MEDICINAL PRODUCT Memantine Mylan 20 mg film-coated tablets memantine hydrochloride
Croatian: NAZIV GOTOVOG LIJEKA Memantin Mylan 20 mg filmom obložene tablete memantinklorid
English: A dark yellow film-coated, tapered oblong shaped, biconvex tablet debossed with “ME” on the left of the score and “10” on the right of the score on one side of the tablet and a score on the other side.
Croatian: Memantin Mylan 10 mg filmom obložene tablete Tamnožuta filmom obložena bikonveksna tableta, suženog, duguljastog oblika, s ugraviranom oznakom „ME“ na lijevoj strani razdjela i oznakom „10“ na desnoj strani razdjela na jednoj strani tablete i razdjelom na drugoj strani.
English: EU/1/13/827/021 14 film-coated tablets
Croatian: EU/1/13/827/021 14 filmom obloženih tableta
English: STATEMENT OF ACTIVE SUBSTANCE Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna filmom obložena tableta sadrži 10 mg memantinklorida, što odgovara 8,31 mg memantina.
English: This overview was last updated in 06-2018.
Croatian: Ovaj pregled informacija posljednji je put ažuriran u 06. 2018.
English: Further information on PecFent can be found on the Agency's website: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Više informacija o lijeku PecFent nalazi se na internetskim stranicama Agencije: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
English: Patients should not take more than four doses a day and should leave a gap of at least four hours between treating each episode of pain.
Croatian: Bolesnici ne bi trebali uzimati više od četiri doze dnevno i trebaju imati pauzu u trajanju od najmanje četiri sata između liječenja svake epizode boli.
English: This means that it is similar to ‘reference medicines' containing the same active substance, but given in a different way.
Croatian: To znači da je sličan „referentnim lijekovima” koji sadržavaju istu djelatnu tvar, ali se primjenjuju na drugačiji način.
English: The doses should be given as either one spray or two sprays of the same strength.
Croatian: Doze se trebaju davati kao jedan potisak ili dva potiska iste jačine.
English: It is a well-known substance, which has been used to control pain for many years.
Croatian: Radi se o dobro poznatoj tvari koja se već godinama upotrebljava za kontrolu boli.
English: The first trial dose should always be 100 micrograms (one spray into one nostril).
Croatian: Prva ispitna doza uvijek treba biti 100 mikrograma (jedan potisak u jednu nosnicu).
English: PecFent (fentanyl)
Croatian: PecFent (fentanil)
English: This means that because the medicine can be misused or cause addiction, it is used under stricter conditions than normal.
Croatian: To znači da se, budući da se lijek može zlouporabiti ili uzrokovati ovisnost, primjenjuje pod strožim uvjetima od uobičajenih.
English: It must not be used to treat short-term pain other than breakthrough pain.
Croatian: Ne smije se koristiti za liječenje kratkoročne boli osim probijajuće boli.
English: The average reduction in pain during the first 30 minutes after use was 6.6 points in patients receiving PecFent compared with 4.5 in those receiving placebo.
Croatian: Prosječno smanjenje boli tijekom prvih 30 minuta nakon primjene iznosilo je 6,6 bodova u bolesnika koji su primali PecFent u usporedbi s 4,5 u osoba koje su primale placebo.
English: PecFent is a ‘hybrid medicine'.
Croatian: PecFent je „hibridni lijek”.
English: The patient should be monitored carefully while the dose is increased.
Croatian: Bolesnika valja pažljivo pratiti dok se doza povećava.
English: PecFent is available as a nasal spray (100 and 400 micrograms per spray) and can only be obtained by ‘special' prescription.
Croatian: PecFent je dostupan kao sprej za nos (100 i 400 mikrograma po potisku) i može se dobiti samo na „poseban” recept.
English: What measures are being taken to ensure the safe and effective use of PecFent?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka PecFent?
English: PecFent received a marketing authorisation valid throughout the EU on 31 August 2010.
Croatian: Lijek PecFent je dobio odobrenje za stavljanje lijeka u promet koje je na snazi u EU-u od 31. kolovoza 2010.
English: The main measure of effectiveness was the change in the severity of pain measured by the patients ranking their pain on a scale from 0 to 10.
Croatian: Glavna mjera djelotvornosti bila je promjena u razini boli koju su izmjerili bolesnici koji su ocijenili svoju bol na ljestvici od 0 do 10.
English: Other information about PecFent:
Croatian: Ostale informacije o lijeku PecFent:
English: The most serious of these side effects are respiratory depression (inhibition of breathing), circulatory depression (slow heartbeat), hypotension (low blood pressure) and shock (a steep fall in blood pressure).
Croatian: Najozbiljnije su nuspojave respiratorna depresija (inhibicija disanja), cirkulatorna depresija (sporo kucanje srca), hipotenzija (niski krvni tlak) i šok (značajni pad krvnog tlaka).
English: In this study, patients reported that they were ‘satisfied' or ‘very satisfied' with PecFent treatment for around 90% of breakthrough pain episodes.
Croatian: Bolesnici u ovom ispitivanju prijavili su da su „zadovoljni” ili „vrlo zadovoljni” liječenjem lijekom PecFent za oko 90 % epizoda probijajuće boli.
English: Because PecFent is a hybrid medicine, the applicant presented data on the reference medicines in addition to results from its own studies.
Croatian: Budući da je PecFent hibridni lijek, podnositelj zahtjeva predstavio je podatke o referentnim lijekovima, kao i rezultate vlastitih ispitivanja.
English: Based on available data, the Agency concluded that PecFent's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Na temelju dostupnih podataka Agencija je zaključila da koristi od lijeka PecFent nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: What is PecFent and what is it used for?
Croatian: Što je PecFent i za što se primjenjuje?
English: The company that markets PecFent will provide educational materials in each EU Member State to make sure that patients, doctors and pharmacists are aware of how PecFent should be used, the risk of accidental exposure to fentanyl and how to dispose of the medicine.
Croatian: Tvrtka koja stavlja lijek PecFent u promet dostavit će edukacijske materijale u svakoj državi članici EUa kako bi zajamčila da bolesnici, liječnici i ljekarnici znaju kako treba primjenjivati PecFent, da su upoznati s rizikom od slučajne izloženosti fentanilu i da znaju kako odložiti lijek.
English: What are the risks associated with PecFent?
Croatian: Koji su rizici povezani s lijekom PecFent?
English: When a patient starts to take PecFent the doctor will need to work out the appropriate dose that will provide adequate pain relief with as few side effects as possible.
Croatian: Kada bolesnik počne uzimati lijek PecFent, liječnik će morati odrediti prikladnu dozu koja će omogućiti potrebno ublažavanje boli uz što je moguće manje nuspojava.
English: Side effects reported with PecFent are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek PecFent pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: The European Medicines Agency noted that there was a need for fast-acting pain medicines for breakthrough pain in patients with cancer.
Croatian: Europska agencija za lijekove primijetila je da postoji potreba za lijekovima s brzim djelovanjem za probijajuću bol u bolesnika s rakom.
English: For more information about using PecFent, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka PecFent, pogledajte uputu o lijeku ili se obratite liječniku ili ljekarniku.
English: When the patient sprays PecFent into the nose, a dose of fentanyl is rapidly absorbed into the blood stream through the blood vessels in the nose.
Croatian: Kada bolesnik potisne sprej PecFent u nos, doza fentanila brzo se apsorbira u krvotok putem krvnih žila u nosu.
English: The doctor should keep in mind the potential for PecFent to be abused.
Croatian: Liječnik bi trebao imati na umu mogućnost zlouporabe lijeka PecFent.
English: As for all medicines, data on the use of PecFent are continuously monitored.
Croatian: Kao za sve lijekove, podatci o primjeni lijeka PecFent kontinuirano se prate.
English: An overview of PecFent and why it is authorised in the EU
Croatian: Pregled informacija o lijeku PecFent i zašto je odobren u EU-u
English: Why is PecFent authorised in the EU?
Croatian: Zašto je lijek PecFent odobren u EU-u?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of PecFent have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka PecFent nalaze se također u sažetku opisa svojstava lijeka i u uputi o lijeku.